Fig. 3.
From: Chlamydia spp. development is differentially altered by treatment with the LpxC inhibitor LPC-011
Amino acid composition of LpxC does not explain differential sensitivity to LPC-011. a Phylogenic-tree analysis of the LpxC enzyme in the Chlamydia species used in this study aligned to E. coli LpxC. b Clustal-W Alignment of the first 300 amino acids of LpxC. Numbering refers to amino acid position in the E. coli LpxC. Residues that are likely involved in LPC interactions are shaded